Listen "Potential for Self-Guided Dosing in Ketamine Infusion Therapy"
Episode Synopsis
Dive into the future of personalized mental healthcare! This episode explores a groundbreaking study on DMT published in Neuropsychopharmacology, revealing how self-guided dosing could revolutionize ketamine therapy. Discover how this approach, where participants adjusted their own dose, not only allowed them to reach deep psychedelic effects but also didn’t increase negative side effects, hinting at a future of safer, more effective, and empowering treatment experiences. Learn what this means for finding your “sweet spot” in healing and the incredible potential of patient control in psychedelic medicine.
Rudin, D., Erne, L., Vogt, S. B., Müller, L., Nuraj, A., Becker, A., et al. (2024). Acute dose-dependent effects and self-guided titration of continuous N,N-dimethyltryptamine infusions in a double-blind placebo-controlled study in healthy participants. Neuropsychopharmacology, 50(6), 1008–1016. https://doi.org/10.1038/s41386-024-02041-8
The post Potential for Self-Guided Dosing in Ketamine Infusion Therapy appeared first on Talking Ketamine Podcast.
More episodes of the podcast Talking Ketamine Podcast
The Science of Dissociation
25/12/2025
Ketamine Reimagined
19/12/2025
Ketamine and Sickle Cell Disease
12/12/2025
Will Ketamine Work for Me?
04/12/2025
Ketamine and Longevity
06/11/2025
Ketamine and Longevity
06/11/2025
A Flawed Ketamine Trial?
30/10/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.